| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes
|
Multinu, Francesco
|
|
|
31 |
4 |
p. 537-544
|
artikel
|
| 2 |
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy
|
van den Heerik, Anne Sophie V M
|
|
|
31 |
4 |
p. 594-604
|
artikel
|
| 3 |
An update on cervical cancer screening in Vanuatu
|
Allanson, Emma R
|
|
|
31 |
4 |
p. 631-632
|
artikel
|
| 4 |
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial
|
Gonzalez Martin, Antonio
|
|
|
31 |
4 |
p. 617-622
|
artikel
|
| 5 |
A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082)
|
Furusawa, Akiko
|
|
|
31 |
4 |
p. 623-626
|
artikel
|
| 6 |
Atypical polypoid adenomyoma
|
Grindstaff, Samuel
|
|
|
31 |
4 |
p. 639-640
|
artikel
|
| 7 |
Clear cell carcinoma of the ovary: a clinical and molecular perspective
|
Iida, Yasushi
|
|
|
31 |
4 |
p. 605-616
|
artikel
|
| 8 |
Clinical features and prognostic factors of cervical villoglandular adenocarcinoma
|
Chen, Jia-Hua
|
|
|
31 |
4 |
p. 512-517
|
artikel
|
| 9 |
Correction: Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series
|
|
|
|
31 |
4 |
p. e1
|
artikel
|
| 10 |
Correction: Int J Gynecol Cancer 2020; 30: multiple articles
|
|
|
|
31 |
4 |
p. e2
|
artikel
|
| 11 |
Correction: 255 Mirrors trial: minimally invasive robotic surgery, role in optimal debulking ovarian cancer, recovery & survival
|
|
|
|
31 |
4 |
p. e4
|
artikel
|
| 12 |
Correction: 254 Robotic corpus cancer surgery: ten year mortality data from the UK epicentre in guildford
|
|
|
|
31 |
4 |
p. e3
|
artikel
|
| 13 |
Correction: 580 Surgical management of gynecologic cancers during the COVID-19 pandemic
|
|
|
|
31 |
4 |
p. e5
|
artikel
|
| 14 |
Emergency department utilization by patients with gynecologic cancer in the United States
|
Albright, Benjamin B
|
|
|
31 |
4 |
p. 585-593
|
artikel
|
| 15 |
Giant port-site recurrence after laparoscopic-staging for endometrial cancer
|
Chiva, Luis
|
|
|
31 |
4 |
p. 641
|
artikel
|
| 16 |
Impact of anesthesia technique on post-operative opioid use in open gynecologic surgery in an enhanced recovery after surgery pathway
|
Lasala, Javier
|
|
|
31 |
4 |
p. 569-574
|
artikel
|
| 17 |
Laparoscopic radical pelvic dissection for safely removing a large cervical myoma
|
Chen, Mo
|
|
|
31 |
4 |
p. 633-634
|
artikel
|
| 18 |
Long-term quality of life outcomes of women treated for early-stage endometrial cancer
|
Sanjida, Saira
|
|
|
31 |
4 |
p. 530-536
|
artikel
|
| 19 |
Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis
|
Rodriguez, Juliana
|
|
|
31 |
4 |
p. 504-511
|
artikel
|
| 20 |
Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission
|
Smaletz, Oren
|
|
|
31 |
4 |
p. 562-568
|
artikel
|
| 21 |
Physical activity levels among ovarian cancer survivors: a prospective longitudinal cohort study
|
Jones, Tamara
|
|
|
31 |
4 |
p. 553-561
|
artikel
|
| 22 |
PleurX indwelling pleural catheter for the treatment of recurrent pleural effusion in advanced ovarian cancer
|
Boria, Felix
|
|
|
31 |
4 |
p. 635-636
|
artikel
|
| 23 |
Radiotherapy dose escalation on pelvic lymph node control in patients with cervical cancer
|
Gogineni, Emile
|
|
|
31 |
4 |
p. 524-529
|
artikel
|
| 24 |
Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer
|
Cibula, David
|
|
|
31 |
4 |
p. 502-503
|
artikel
|
| 25 |
Recurrence of vulvar squamous cell carcinoma as an undifferentiated sarcomatoid carcinoma
|
Comerio, Chiara
|
|
|
31 |
4 |
p. 627-630
|
artikel
|
| 26 |
Risk of second malignancy in patients with ovarian clear cell carcinoma
|
Van Nguyen, Julie My
|
|
|
31 |
4 |
p. 545-552
|
artikel
|
| 27 |
Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study
|
Salvo, Gloria
|
|
|
31 |
4 |
p. 495-501
|
artikel
|
| 28 |
Stage IVA cervical cancer: outcomes of disease related complications and treatment
|
Khulpateea, Beman Roy
|
|
|
31 |
4 |
p. 518-523
|
artikel
|
| 29 |
Subspecialty training in Europe: a report by the European Network of Young Gynaecological Oncologists
|
Lanner, Maximilian
|
|
|
31 |
4 |
p. 575-584
|
artikel
|
| 30 |
The IJGC Editorial Fellowship
|
Angeles, Martina Aida
|
|
|
31 |
4 |
p. 644-645
|
artikel
|
| 31 |
Ultrasound, macroscopic and histological features of serous epithelial ovarian carcinomas
|
Romeo, Paola
|
|
|
31 |
4 |
p. 637-638
|
artikel
|
| 32 |
What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer?
|
Batista, Thales Paulo
|
|
|
31 |
4 |
p. 642-643
|
artikel
|
Tijdschrift beschrijving